U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
− ENTYVIO is Now Available in the U.S. in Both IV and Subcutaneous Administrations for…
− ENTYVIO is Now Available in the U.S. in Both IV and Subcutaneous Administrations for…
PARIS--(BUSINESS WIRE)--A crayon drawing depicting doves soaring around the Olympic rings, connecting Beijing’s Temple of…
DUBLIN--(BUSINESS WIRE)--The "Logistics Automation Market by Offering (Hardware, Software, Services), Type (Inbound, Outbound), Automation Mode,…
- Targeting Net Zero Across Value Chain by 2050 - TOKYO--(BUSINESS WIRE)--OKI (TOKYO: 6703) has…
The company carries LBMA certification of 99.99% pure silver and its Sindesar Khurd Mine stands…
LONDON--(BUSINESS WIRE)--Rio Tinto has donated US$1.5 million to the Icelandic Red Cross to support the…
PITTSBURGH--(BUSINESS WIRE)--CEI, a leading provider of technology strategy, solutions, and services, today announced the acquisition…
The funding comes on the heels of rapid growth and launch of new solutions SAN…
BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--TriMas Packaging, the largest division of TriMas (NASDAQ: TRS), will exhibit its…
New data from the largest European real-world evidence study of cefiderocol demonstrate positive outcomes including…